EFFICACY OF EPIDERMAL GROWTH FACTOR RECEPTOR TYROSINE KINASE INHIBITORS FOR BRAIN METASTASIS IN NON-SMALL CELL LUNG CANCER PATIENTS HARBORING EITHER EXON 19 OR 21 MUTATIONS

被引：0

作者：

Kim, Kyu-Pyo ^{[1
]}

Lee, Dae-Ho ^{[1
]}

Lee, Jungshin J. ^{[1
]}

Suh, Cheolwon ^{[1
]}

Kim, Sang-We ^{[1
]}

Lee, Jae Cheol ^{[1
]}

Choi, Chang-Min ^{[1
]}

Jang, Se Jin ^{[1
]}

Choi, Jene ^{[1
]}

机构：

[1] Univ Ulsan, Asan Med Ctr, Ulsan, South Korea

来源：

JOURNAL OF THORACIC ONCOLOGY | 2011年 / 6卷 / 06期

关键词：

Brain Metastasis; EGFR mutations; EGFR TKI;

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：S657 / S657

页数：1

共 50 条

[1] Efficacy of epidermal growth factor receptor tyrosine kinase inhibitors for brain metastasis in non-small cell lung cancer patients harboring either exon 19 or 21 mutations.
Kim, K.
Lee, D. H.
Lee, J.
Suh, C.
Kim, S.
Lee, J. C.
Choi, C.
Jang, S. J.
Choi, J.
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
[2] Efficacy of epidermal growth factor receptor tyrosine kinase inhibitors for brain metastasis in non-small cell lung cancer patients harboring either exon 19 or 21 mutation
Park, S. J.
Kim, H. T.
Lee, D. H.
Kim, K. P.
Kim, S. -W.
Suh, C.
Lee, J. S.
[J]. LUNG CANCER, 2012, 77 (03) : 556 - 560
[3] Activity of Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors in Patients with Non-small Cell Lung Cancer Harboring Rare Epidermal Growth Factor Receptor Mutations
De Pas, Tommaso
Toffalorio, Francesca
Manzotti, Michela
Fumagalli, Caterina
Spitaleri, Gianluca
Catania, Chiara
Delmonte, Angelo
Giovannini, Monica
Spaggiari, Lorenzo
de Braud, Filippo
Barberis, Massimo
[J]. JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (11) : 1895 - 1901
[4] Survival of patients with brain metastases from non-small cell lung cancer harboring EGFR mutations treated with epidermal growth factor receptor tyrosine kinase inhibitors
Jumpei Kashima
Yusuke Okuma
Maki Miwa
Yukio Hosomi
[J]. Medical Oncology, 2016, 33
[5] Survival of patients with brain metastases from non-small cell lung cancer harboring EGFR mutations treated with epidermal growth factor receptor tyrosine kinase inhibitors
Kashima, Jumpei
Okuma, Yusuke
Miwa, Maki
Hosomi, Yukio
[J]. MEDICAL ONCOLOGY, 2016, 33 (11)
[6] Clinical characteristics and response to tyrosine kinase inhibitors of patients with non-small cell lung cancer harboring uncommon epidermal growth factor receptor mutations
Yan Zhang
Zheng Wang
Xuezhi Hao
Xingsheng Hu
Hongyu Wang
Yan Wang
Jianming Ying
[J]. Chinese Journal of Cancer Research, 2017, 29 (01) : 18 - 24
[7] Clinical characteristics and response to tyrosine kinase inhibitors of patients with non-small cell lung cancer harboring uncommon epidermal growth factor receptor mutations
Zhang, Yan
Wang, Zheng
Hao, Xuezhi
Hu, Xingsheng
Wang, Hongyu
Wang, Yan
Ying, Jianming
[J]. CHINESE JOURNAL OF CANCER RESEARCH, 2017, 29 (01) : 18 - 24
[8] Smoking History as a Predictor of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Patients with Non-Small Cell Lung Cancer Harboring EGFR Mutations
Nishinarita, Noriko
Igawa, Satoshi
Kasajima, Masashi
Kusuhara, Seiichiro
Harada, Shinya
Okuma, Yuriko
Sugita, Keisuke
Ozawa, Takahiro
Fukui, Tomoya
Mitsufuji, Hisashi
Yokoba, Masanori
Katagiri, Masato
Kubota, Masaru
Sasaki, Jiichiro
Naoki, Katsuhiko
[J]. ONCOLOGY, 2018, 95 (02) : 109 - 115
[9] Effectiveness Of Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors On Non-Small Cell Lung Cancer Harboring Rare EGFR Mutations
Chang, L. -C.
Chen, K. -Y.
Shih, J. -Y.
[J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
[10] Epidermal growth factor receptor tyrosine kinase inhibitors for non-small cell lung cancer
Asami, Kazuhiro
Atagi, Shinji
[J]. WORLD JOURNAL OF CLINICAL ONCOLOGY, 2014, 5 (04): : 646 - 659

← 1 2 3 4 5 →